Euglenophycin Synthesis and Clinical Evaluation for Cancer Treatment

Title:  Euglenophycin Synthesis and Clinical Evaluation for Cancer Treatment

Principal Investigator: Paul V. Zimba, Ph.D.

Collaborating Institutions: Texas A & M University – Corpus Christi, Medical University of South Carolina, North Carolina State University, NOAA

Publications:  Mehrubeoglu M, Teng MY, Savage M, Rafalski A, Zimba PV:  Hyperspectral imaging and analysis of mixed algae species in liquid media.  IEEE International Conference on Imaging Systems and Techniques (IST) 2012; 421 - 424

Gutierrez D, Rafalski A, Moeller P, Beauchesne K, Zimba PV:  In Press: Quantitative mass spectrometric analysis and post-extraction stability assessment of the euglenoid toxin euglenophycin.  Journal of Geology and Geosciences 

Book Chapters/Reports:  Westrick JA, Southwell B, Szlag D, Zimba, PV:  Chapter 3: Detection of Cyanotoxins During Potable Water Treatment. In AWWA: Algae Source to Treatment (book chapter) 2010

Natural Research Council (NAS):  Sustainable Development of Algal Biofuels in the United States. 

ISBN-10: 0-309-26032-9:  2012; 259

Papers in preparation/in review from Lichtenstein funded researchBertin MJ, Huncik K, Beauchesne K, Moeller PD, Triemer R, Zimba PV:  In Review:  Euglenaxanthin-a new carotenoid from euglenoids including the harmful alga Euglena sanguinea. J. Phycology

Zimba PV, Gutierrez D, Ordner P, Rafalski, A, Savage ML, Treimer R: In review:Evidence for euglenophycin occurrence in saline environments: field and laboratory studies. Marine Toxins

Previous
Previous

Testing the Implementation and Effectiveness of a Low-Literacy Diabetes Self-Management Education Kiosk

Next
Next

CHRISTUS Spohn Hospital Health System Corpus Christi - Neural Tube Defect Incidence and Intervention Study